ResearcherShenzhen UniversityActive in the last 2 years

Xundi Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4287-4358; OpenAlex author ID A5023934433. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signaling pathway. Last author DOI 10.1038/s41419-024-07324-y ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shiyu Chen · 1 shared paper, 2024 · strength 0.22
- Paper TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signa… DOI 10.1038/s41419-024-07324-y ↗
Kun Cai · 1 shared paper, 2024 · strength 0.22
- Paper TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signa… DOI 10.1038/s41419-024-07324-y ↗
Zhiwei He · 1 shared paper, 2024 · strength 0.22
- Paper TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signa… DOI 10.1038/s41419-024-07324-y ↗
Yan Zhang · 1 shared paper, 2024 · strength 0.22
- Paper TRIM59/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signa… DOI 10.1038/s41419-024-07324-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.